$SHOP

Cathie Wood’s ARK sells Shopify stock, buys Cerebras Systems

Investing.com reports Cathie Wood’s ARK ETFs published Thursday trades. ARK bought 106,941 shares of Cerebras Systems (CBRS) for about $28.0M and bought Securitize (SECZ) and Perceptive Capital Solutions (FRNM). It sold Shopify (SHOP) 57,045 shares for about $8.6M and sold Palantir (PLTR) for about $7.5M, plus other smaller trades.

Original reporting
Published Aug 14, 2026, 12:12 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 4:13 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$SHOP
Neutral
medium confidence
Mentioned
$SHOP · $CBRS · $PLTR · $SECZ · $FRNM · $SDGR
Relevance
4/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$SHOPNeutralLow
01

Why it matters

For traders, the actionable element is the disclosed flow into or out of specific tickers, which can influence short-term sentiment but is not presented as a fundamental catalyst.

02

Market read

This is a fund-flow and sentiment read-through from ARK’s disclosed trades, with mixed direction across the named tickers.

03

What to watch

The article does not state ARK’s total position sizes, cost basis, or whether trades are part of a pre-planned rebalance, limiting inference about conviction.

Relevance 4/10Novelty 3/10Timing: daily ARK trade disclosure for Aug 13, 2026

Background

The piece summarizes ARK ETF daily trades for Aug 13, 2026, highlighting several buys and sells across multiple holdings.

Company-level read

Ticker impact

$SHOPNeutralMedium confidence
Context

ARK sold 57,045 shares of Shopify across ARKK, ARKW, and ARKF, continuing a multi-day position reduction.

Expected impact

Likely limited near-term impact unless follow-on selling accelerates or coincides with other SHOP-specific news.

Evidence & confidence

The article provides only disclosed trade sizes and does not cite new Shopify fundamentals, guidance, or regulatory/product events.

$CBRSBullishMedium confidence
Context

ARK bought 106,941 shares of Cerebras Systems, totaling about $28.0M, split between ARKK and ARKW.

Expected impact

Mild positive bias for sentiment, with follow-through dependent on broader market and CBRS-specific catalysts not mentioned here.

Evidence & confidence

The article is a daily ARK trade disclosure; it does not include new CBRS financial results, contracts, or trial/regulatory milestones.

$PLTRBearishLow confidence
Context

ARK sold 43,874 shares of Palantir for about $7.5M, continuing a pattern of selling over the past few days.

Expected impact

Potential short-term drag if traders interpret it as reduced conviction, but magnitude is unclear versus total fund holdings.

Evidence & confidence

The text shows trade activity only; it does not provide PLTR-specific negative news or a stated rationale.

$SECZBullishLow confidence
Context

ARK acquired 192,702 shares of Securitize through ARKF, totaling about $1.51M.

Expected impact

Limited impact unless the buying is part of a larger, sustained accumulation trend.

Evidence & confidence

The article provides only the disclosed purchase size and no additional SECZ catalyst.

$FRNMBullishLow confidence
Context

ARK increased holdings in Perceptive Capital Solutions by buying 123,842 shares for about $1.43M.

Expected impact

Likely negligible to small near-term effect on price absent other news.

Evidence & confidence

No FRNM-specific developments are described beyond the trade disclosure.

$SDGRBullishLow confidence
Context

ARK bought 28,179 shares of Schrodinger via ARKG for about $0.52M.

Expected impact

Minimal impact expected based solely on this disclosed trade size.

Evidence & confidence

The text does not mention trial results, approvals, or guidance changes for SDGR.

$TXGBearishLow confidence
Context

ARK sold 51,171 shares of 10X Genomics for about $2.96M.

Expected impact

Limited near-term impact unless it reflects a broader de-risking trend.

Evidence & confidence

The article provides trade activity only and no TXG-specific negative event.

Market effects

Flow signals across software/AI (PLTR, CBRS), e-commerce (SHOP), and biotech/life sciences tools (SDGR, TXG) without sector-wide fundamental drivers.

Primarily US-listed names; no cross-region macro or policy linkage beyond a brief market wrap.

No direct global linkage; trades are fund-specific rather than tied to global events.

Counterpoint

ARK trade disclosures can be driven by portfolio rebalancing, liquidity management, or ETF mechanics, so the market may overreact to the headline buys/sells.

Key entities

  • ARK ETFs (ARKK, ARKW, ARKF, ARKG)

    Cathie Wood’s ARK exchange-traded funds that executed the disclosed trades.

  • Shopify Inc.

    ARK reduced its position via a reported sale of shares across multiple ARK ETFs.

  • Cerebras Systems Inc.

    ARK added shares via a reported purchase split between ARKK and ARKW.

  • Palantir Technologies Inc.

    ARK sold shares, continuing a recent selling pattern described in the article.

Related articles

$ABNBMedAI 8/10

Airbnb vs. Shopify: Which Consumer Stock Is a Better Buy in 2026?

Shopify reported strong financials in 2025, including zero debt, high liquidity, and $2B+ free cash flow. Airbnb faces regulatory and tax risks but showed strong Q2 2026 results, with $3.6B revenue and $14.1B full-year sales forecast. Shopify also reported strong Q3 2026 results, with $3.58B revenue and 34% YoY growth. Airbnb is seen as more conservatively valued.

$SHOPMedAI 8/10

Where Will Shopify Stock Be in 5 Years?

Shopify (SHOP) reported 34% revenue growth to $3.6B in Q2, with GMV up 32% to $115.6B. GMV growth has accelerated yearly, reaching 29% in 2025. The stock trades at $148, 19% below its 52-week high. Shopify's take rate is 3.1%, with merchant solutions revenue growing 37%. The company's market cap is $190B, trading at 14x sales and 80x free cash flow. Analysts discuss future growth prospects and valuation.

$PLTRMedAI 8/10

Palantir just won the Army and lost Michael Burry

Palantir Technologies (PLTR) secured a new Army contract and expanded its alliance with PwC, while investor Michael Burry criticized its financials, suggesting its market value could fall below $100 billion. Burry highlighted Palantir's deferred revenue ratio and rising accounts receivable as concerns. Despite Burry's bearish outlook, Palantir's stock rose nearly 7% on the PwC alliance news, according to Benzinga.